Subsequently, by using spatial transcriptomics, we provided spatial evidence at the in-situ tissue level, revealing a pattern of spatial exclusion between SASH1 expression and the fibrotic tumor microenvironment. This evidence concerns the gene SASH1 and neoplasm.